Study (23) | Historical control (29) | |
---|---|---|
Lost for follow-up | 1 | 0 |
Follow-up (months) | ||
Median | 20 | 31 |
Range | 1–39 | 1–48 |
Alive | 14 (63.6%) | 21 (72.4%) |
Local recurrences | 5 (22.7%) | 5 (17.2%) |
Regional recurrences | 2 (9%) | 2 (6.9%) |
Distant metastases | 2 (9%) | 4 (13.8%) |
Death during treatment | 2 (1 aspiration pneumonia, 1 disease progression) | 0 |